| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |